[EN] PROGRANULIN MODULATORS AND METHODS OF USING THE SAME<br/>[FR] MODULATEURS DE PROGRANULINE ET LEURS PROCÉDÉS D'UTILISATION
申请人:ARKUDA THERAPEUTICS
公开号:WO2019118528A1
公开(公告)日:2019-06-20
Provided herein are compounds that modulate progranulin and methods of using the compounds in progranulin-associated disorders, such as Frontotemperal dementia (FTD).
提供了一种调节颗粒蛋白的化合物及其在颗粒蛋白相关疾病(如额颞叶痴呆(FTD))中的应用方法。
Phencyclidine-like effects of tetrahydroisoquinolines and related compounds
作者:Nancy M. Gray、Brian K. Cheng、Stephen J. Mick、Cecelia M. Lair、Patricia C. Contreras
DOI:10.1021/jm00126a016
日期:1989.6
3-c]pyridines, and relatedcompounds were evaluated for their ability to inhibit binding of [3H]-1-[1-(2-thienyl)piperidine and [3H]-N-allylnormetazocine to phencyclidine (PCP) and sigma receptors, respectively. A representative series of compounds was evaluated in behavioral assays to determine the ability of the compounds to induce PCP-like stereotyped behavior and ataxia. All of the compounds caused stereotyped
Diprotonative stabilization of ring-opened carbocationic intermediates: conversion of tetrahydroisoquinoline to triarylmethanes
作者:Hiroaki Kurouchi
DOI:10.1039/d0cc01969k
日期:——
Superacid-promoted conversion of tetrahydroisoquinolines to triarylmethanes via tandem reactions of C–N bond scission, Friedel–Crafts alkylation, C–O bond scission, and electrophilic aromatic amidation was developed. Dication formation was important for stabilizing the ring-opened carbocationic intermediate, which is a new role for diprotonation in reaction mechanisms.
Quinuclidine derivatives and medicinal composition thereof
申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US06017927A1
公开(公告)日:2000-01-25
Quinuclidine derivatives represented by general following general formula (I), salts, N-oxides or quaternary ammonium salts thereof, and medicinal compositions containing the same. ##STR1## The compound has an antagonistic effect on muscarinic M.sub.3 receptors and is useful as a preventive or remedy for urologic diseases, respiratory diseases or digestive diseases.
An unusual solvent DMF-promoted dehydrogenation of 1-substituted 1,2,3,4-tetrahydroisoquinolines to synthesize cyclic imines is described. This environmentally friendly reaction features no requirement of any metal catalysts, oxidants, or hydrogenacceptors. A wide range of structurally varied 3,4-dihydroisoquinolines can be obtained with good yields and excellent chemoselectivities.